FI98987B - Varjoainekoostumus - Google Patents

Varjoainekoostumus

Info

Publication number
FI98987B
FI98987B FI920237A FI920237A FI98987B FI 98987 B FI98987 B FI 98987B FI 920237 A FI920237 A FI 920237A FI 920237 A FI920237 A FI 920237A FI 98987 B FI98987 B FI 98987B
Authority
FI
Finland
Prior art keywords
contrast medium
medium composition
enhancing agent
physiologically tolerable
magnetically responsive
Prior art date
Application number
FI920237A
Other languages
English (en)
Swedish (sv)
Other versions
FI920237A0 (fi
FI98987C (fi
Inventor
Helge Guttorm Gundersen
Original Assignee
Nycomed As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed As filed Critical Nycomed As
Publication of FI920237A0 publication Critical patent/FI920237A0/fi
Publication of FI98987B publication Critical patent/FI98987B/fi
Application granted granted Critical
Publication of FI98987C publication Critical patent/FI98987C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1887—Agglomerates, clusters, i.e. more than one (super)(para)magnetic microparticle or nanoparticle are aggregated or entrapped in the same maxtrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1803—Semi-solid preparations, e.g. ointments, gels, hydrogels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1857—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. PLGA

Landscapes

  • Health & Medical Sciences (AREA)
  • Nanotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Radiology & Medical Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Liquid Crystal Substances (AREA)
  • Electrochromic Elements, Electrophoresis, Or Variable Reflection Or Absorption Elements (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
FI920237A 1989-07-21 1992-01-20 Varjoainekoostumus FI98987C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB898916780A GB8916780D0 (en) 1989-07-21 1989-07-21 Compositions
GB8916780 1989-07-21
EP9001196 1990-07-19
PCT/EP1990/001196 WO1991001148A1 (en) 1989-07-21 1990-07-19 Contrast medium composition

Publications (3)

Publication Number Publication Date
FI920237A0 FI920237A0 (fi) 1992-01-20
FI98987B true FI98987B (fi) 1997-06-13
FI98987C FI98987C (fi) 1997-09-25

Family

ID=10660459

Family Applications (1)

Application Number Title Priority Date Filing Date
FI920237A FI98987C (fi) 1989-07-21 1992-01-20 Varjoainekoostumus

Country Status (16)

Country Link
EP (2) EP0485429A1 (fi)
JP (1) JP2962521B2 (fi)
AT (1) ATE101047T1 (fi)
AU (1) AU640401B2 (fi)
CA (1) CA2059279A1 (fi)
DE (1) DE69006415T2 (fi)
DK (1) DK0409351T3 (fi)
ES (1) ES2048958T3 (fi)
FI (1) FI98987C (fi)
GB (1) GB8916780D0 (fi)
HK (1) HK1003562A1 (fi)
IE (1) IE65463B1 (fi)
NO (1) NO303483B1 (fi)
NZ (1) NZ234574A (fi)
WO (1) WO1991001148A1 (fi)
ZA (1) ZA905725B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5114703A (en) * 1989-05-30 1992-05-19 Alliance Pharmaceutical Corp. Percutaneous lymphography using particulate fluorocarbon emulsions
US5368840A (en) * 1990-04-10 1994-11-29 Imarx Pharmaceutical Corp. Natural polymers as contrast media for magnetic resonance imaging
ES2138122T3 (es) * 1990-04-10 2000-01-01 Imarx Pharmaceutical Corp Polimeros como medios de contraste para resonancia magnetica.
US5370901A (en) * 1991-02-15 1994-12-06 Bracco International B.V. Compositions for increasing the image contrast in diagnostic investigations of the digestive tract of patients
US5179955A (en) * 1991-02-22 1993-01-19 Molecular Biosystems, Inc. Method of abdominal ultrasound imaging
US5455308A (en) * 1991-08-01 1995-10-03 Dsm N.V. Endless objects from epoxy resin or unsaturated polyester and thermoplastic polymer
JPH06157355A (ja) * 1992-11-13 1994-06-03 Dai Ichi Seiyaku Co Ltd Ｍｒｉ用粒状製剤
FR2703250A1 (fr) * 1993-03-30 1994-10-07 Chicouri Marcel Nouvelles compositions pharmaceutiques à base de bismuth et leur procédé de préparation.
DE4426204C2 (de) * 1993-07-24 2001-05-23 Infai Inst Fuer Biomedizinisch Diagnostikum und seine Verwendung
JP2909876B2 (ja) * 1994-01-24 1999-06-23 恭弘 小川 造影剤
WO1995020405A1 (en) * 1994-01-28 1995-08-03 Nycomed Imaging As Oral magnetic particle formulation
EP1031354A3 (en) 1999-01-19 2003-02-05 Rohm And Haas Company Polymeric MRI Contrast agents

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3316703A1 (de) * 1983-05-04 1984-11-08 Schering AG, 1000 Berlin und 4709 Bergkamen Orales kontrastmittel fuer die kernspintomographie und dessen herstellung
SE463651B (sv) 1983-12-21 1991-01-07 Nycomed As Diagnostikum och kontrastmedel
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
SE465907B (sv) * 1984-11-01 1991-11-18 Nyegaard & Co As Diagnosticeringsmedel innehaallande en paramagnetisk metall
DE3577185D1 (de) * 1984-11-01 1990-05-23 Nycomed As Paramagnetische kontrastmittel fuer die anwendung in "in vivo" nmr-diagnostischen methoden und die herstellung davon.
DE3443252A1 (de) 1984-11-23 1986-05-28 Schering AG, 1000 Berlin und 4709 Bergkamen Dextran-magnetit-komplexe fuer die nmr-diagnostik
US4675173A (en) 1985-05-08 1987-06-23 Molecular Biosystems, Inc. Method of magnetic resonance imaging of the liver and spleen
US4729892A (en) * 1986-03-21 1988-03-08 Ciba-Geigy Corporation Use of cross-linked hydrogel materials as image contrast agents in proton nuclear magnetic resonance tomography and tissue phantom kits containing such materials
US4770183A (en) 1986-07-03 1988-09-13 Advanced Magnetics Incorporated Biologically degradable superparamagnetic particles for use as nuclear magnetic resonance imaging agents
DE3709851A1 (de) * 1987-03-24 1988-10-06 Silica Gel Gmbh Adsorptions Te Nmr-diagnostische fluessigkeitszusammensetzungen
SE8704157L (sv) 1987-10-26 1989-04-27 Carbomatrix Ab C O Ulf Schroed Superparamagnetiska partiklar och foerfarande foer framstaellning daerav samt anvaendning

Also Published As

Publication number Publication date
NZ234574A (en) 1992-11-25
ZA905725B (en) 1991-04-24
JPH04506806A (ja) 1992-11-26
AU640401B2 (en) 1993-08-26
FI920237A0 (fi) 1992-01-20
JP2962521B2 (ja) 1999-10-12
HK1003562A1 (en) 1998-10-30
EP0409351B1 (en) 1994-02-02
EP0485429A1 (en) 1992-05-20
IE65463B1 (en) 1995-11-01
ES2048958T3 (es) 1994-04-01
DK0409351T3 (da) 1994-03-07
IE902658A1 (en) 1991-02-27
GB8916780D0 (en) 1989-09-06
CA2059279A1 (en) 1991-01-22
NO303483B1 (no) 1998-07-20
DE69006415D1 (de) 1994-03-17
ATE101047T1 (de) 1994-02-15
NO920263D0 (no) 1992-01-20
EP0409351A1 (en) 1991-01-23
NO920263L (no) 1992-01-20
WO1991001148A1 (en) 1991-02-07
FI98987C (fi) 1997-09-25
AU6147590A (en) 1991-02-22
DE69006415T2 (de) 1994-05-11

Similar Documents

Publication Publication Date Title
FR2651294B1 (fr) Unite d'etancheite.
DE69112601D1 (de) Emulsionszusammensetzung.
TR24655A (tr) Karbon isleri ve karbon islerini iceren kaucuk bilesimleri
DE69001691D1 (de) Statische abdichtung.
ES2045317T3 (es) Protesis.
AU2017488A (en) Antifoam agents
GB2245585B (en) Shampoo composition containing a water-soluble polymer and an anionic surfactant and/or an ampholytic surfactant.
FI98987B (fi) Varjoainekoostumus
DE59100233D1 (de) Luftfrachtpalette.
DE58903011D1 (de) Gesichtsmaske.
DE69006035D1 (de) Kunststoffversiegelung.
DE69023975D1 (de) Tandem-montierte, stirnseitige Dichtungen.
ATE283547T1 (de) Schalter mit selbstbeblasung mit reduzierter kompression
EP0401262A4 (en) 24r-scymnol, and preparation and use thereof
DE69011484D1 (de) Acrylische Kautschuk-Zusammensetzung.
DE69023605D1 (de) Positive Fotolackzusammensetzung.
DE59001992D1 (de) Dichtungsplatten - kalander.
NO900809L (no) Tetningsenhet.
ITRM920231V0 (it) Guarnizione senza amianto, in particolare per freni
FR2671122B3 (fr) Plaque d'etancheite.
ES1012208Y (es) Envase proyectado en reutilizacion dirigida ensamblaje por bayoneta.
FR2654624B1 (fr) Dispositif d'ambiance.
KR920012526U (ko) 세프티 시일 커플링(safety seal coupling)
ATE96521T1 (de) Druckdichte steckkupplung.
ES1011039Y (es) Pizarra infantil.

Legal Events

Date Code Title Description
BB Publication of examined application